<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01230515</url>
  </required_header>
  <id_info>
    <org_study_id>VICC SUPP 0566</org_study_id>
    <secondary_id>P30CA068485</secondary_id>
    <nct_id>NCT01230515</nct_id>
  </id_info>
  <brief_title>Opioid Titration in the Hospice Setting: Barriers Assessment and Modification of the Model Order Sheet and Protocol</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Vanderbilt-Ingram Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>Vanderbilt-Ingram Cancer Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to modify the opioid titration order sheet to meet the needs of
      the outpatient hospice population and to conduct a pilot trial to assess feasibility,
      utility, and derive preliminary efficacy data.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">November 2007</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Adequate pain control</measure>
    <time_frame>Until death.</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Actual">65</enrollment>
  <condition>Cancer Pain</condition>
  <arm_group>
    <arm_group_label>Caregiver</arm_group_label>
    <description>Family members will be asked to complete a demographic survey, an assessment of the patient's current pain, and a series of questionnaires including: Caregiver Pain Medicine Questionnaire, the Stressful Caregiving Adult Reactions To Experiences of Dying Scale, and the Caregivers' Self Efficacy in Pain Management Questionnaire. Upon completion of the questionnaires, patients and caregivers will be interviewed separately.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hospice staff</arm_group_label>
    <description>Hospice staff will be asked to complete the Pain Knowledge and Attitudes survey. They will also complete the Technology Acceptance Model (TAM) questionnaire to assess the perceived utility of an opioid titration order sheet to help manage pain control. A demographic survey will also be completed.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Referring physician</arm_group_label>
    <description>Referring physicians will be asked to complete the Pain Knowledge and Attitudes survey as well as the TAM questionnaire and Demographic Survey.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Patient</arm_group_label>
    <description>Demographic information includes education, marital status, number in household, and employment status will be obtained from patient. Clinical data will be obtained from the patient's medical records. Information to be obtained will include information about the type of cancer, stage of disease, time since diagnosis, current treatment for cancer, type of pain, time since onset of pain, and time of first opioid prescription. The patient will also take a pain assessment survey.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Individual patient interview, focus group and structured survey</intervention_name>
    <arm_group_label>Patient</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>interview, focus group and structured survey</intervention_name>
    <arm_group_label>Caregiver</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>interview, focus group and structured survey</intervention_name>
    <arm_group_label>Hospice staff</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>interview, focus group and structured survey</intervention_name>
    <arm_group_label>Referring physician</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Hospice Staff Caregiver Patient Referring Physician
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patient eligibility includes:

               -  Alive Hospice outpatient

               -  Diagnosis of carcinoma

               -  Pain requiring fixed dose opioids

               -  Age &gt; 21 years

               -  Not pregnant or lactating

               -  Willing and able to sign informed consent

               -  Able to speak/comprehend English

        Caregiver eligibility will include:

          -  Caregiver for an Alive Hospice patient

          -  Willing and able to sign informed consent

          -  Able to speak/comprehend English

        Hospice Staff eligibility will include:

          -  Currently on staff at Alive Hospice

          -  Willing and able to sign informed consent

          -  Able to read/speak English.

        Referring Physician eligibility will include:

          -  Having recently referred patients to Alive Hospice

          -  Willing and able to sign informed consent and able to read/speak English.

        Exclusion Criteria:

          -  patients &lt; 21 years of age

          -  pregnant or lactating

          -  patients, caregiver and or Hospice staff that does not speak/comprehend English
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Barbara Murphy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Vanderbilt-Ingram Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Vanderbilt-Ingam Cancer Center</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 11, 2010</study_first_submitted>
  <study_first_submitted_qc>October 27, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 29, 2010</study_first_posted>
  <last_update_submitted>September 7, 2012</last_update_submitted>
  <last_update_submitted_qc>September 7, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 10, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Vanderbilt-Ingram Cancer Center</investigator_affiliation>
    <investigator_full_name>Barbara Murphy, MD</investigator_full_name>
    <investigator_title>Professor of Medicine; Director, Cancer Supportive Care Program; Director, Head and Neck Research Program; Medical Oncologist</investigator_title>
  </responsible_party>
  <keyword>Oncology Pain Management in outpatient hospice setting</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cancer Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

